MBody AI (MBAI) Stock Price, News & Analysis

Company Overview

MBody AI, Inc. (NASDAQ:MBAI) is a technology company focused on applying artificial intelligence to health, wellness and body-composition management. Its business centers on developing digital tools intended to help users better understand and manage aspects of their fitness, nutrition and overall well-being.

The company’s products and services are designed to use data-driven insights and personalized recommendations to support individual health and wellness goals. Publicly available information about MBody AI’s specific product portfolio, operating geographies and leadership team is limited.

MBody AI is an emerging company, and additional details about its commercial operations and corporate history may become available through future regulatory filings and company disclosures.

Key Stats

• Today's Range: $3.03 to $3.29
• 50-Day Range: $3.16 to $10.01
• 52-Week Range: $3.03 to $27.44
• Volume: 12,350 shs
• Average Volume: 24,032 shs
• Market Capitalization: $4.52 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $10.00
• Consensus Rating: Hold

MBody AI Stock Analysis - MarketRank™

MBody AI scored higher than 66% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.6 / 5
• Analyst Rating: Hold

Consensus Rating

MBody AI has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and 1 sell rating.

Upside Potential

MBody AI has a consensus price target of $10.00, representing about 204.0% upside from its current price of $3.29.

Amount of Analyst Coverage

MBody AI has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of MBody AI is -0.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of MBody AI is -0.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

MBody AI has a P/B Ratio of 1.00. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.55% of the float of MBody AI has been sold short.

Short Interest Ratio / Days to Cover

MBody AI has a short interest ratio ("days to cover") of 0.67, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in MBody AI has recently decreased by 18.30%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

MBody AI does not currently pay a dividend.

Dividend Growth

MBody AI does not have a long track record of dividend growth.

News and Social Media

• Score: 3.1 / 5
• News Sentiment: 1.00

News Sentiment

MBody AI has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.47 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 10 news articles for MBody AI this week, compared to 2 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, MBody AI insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.48% of the stock of MBody AI is held by insiders.

Percentage Held by Institutions

1.07% of the stock of MBody AI is held by institutions.

Company Calendar

• Today: 10/03/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:MBAI
• CIK: 1610590
• Web: www.mbody.ai
• Phone: 972-4-8303400
• Fax: 972-4821-1267
• Employees: 85
• Year Founded: N/A

Price Target and Rating

• Average Price Target for MBody AI: $10.00
• High Price Target: $10.00
• Low Price Target: $10.00
• Potential Upside/Downside: +204.0%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: $4.16 per share
• Price / Cash Flow: 0.79
• Book Value: $3.30 per share
• Price / Book: 1.00

Miscellaneous

• Outstanding Shares: 1,375,000
• Free Float: 1,368,000
• Market Cap: $4.52 million
• Optionable: N/A
• Beta: 0.66